Aseptically Prepared Systemic Anti-Cancer Therapy Medicines
- Mid South Essex NHS Foundation Trust
Procurement identifier (OCID): ocds-h6vhtk-051cde
Description
This framework agreement is for the supply of a range of aseptically prepared, batch manufactured systemic anti-cancer therapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific systemic anti-cancer therapy drugs and medicines used in CIVAs.
Notices
UK6: Contract award notice
- Notice identifier
- 2026/S 000-100972
- Published
- 26 October 2026, 12:28pm
UK4: Tender notice
- Notice identifier
- 2026/S 000-033144
- Published
- 13 April 2026, 10:48am
UK2: Preliminary market engagement notice
- Notice identifier
- 2025/S 000-048018
- Published
- 12 August 2025, 1:02pm
UK1: Pipeline notice
- Notice identifier
- 2025/S 000-024556
- Published
- 22 May 2025, 10:24am